These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23809736)

  • 21. Venous thromboembolism in cancer patients: expanding horizons.
    Bergqvist D
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 24. [Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now].
    Jansson JH
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):1984-5. PubMed ID: 16044753
    [No Abstract]   [Full Text] [Related]  

  • 25. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
    Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term treatment with a low-molecular-weight heparin administered subcutaneously compared with a vitamin K antagonist: subanalysis of patients with cancer].
    Romera-Villegas A; Martí Mestre X; Vila Coll R; Colomé Nafría E
    Med Clin (Barc); 2015 Jan; 144 Suppl 1():16-20. PubMed ID: 25771087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The risk of venous thromboembolism during air travel].
    Sanchez O
    Rev Prat; 2007 Apr; 57(7):721-3. PubMed ID: 17654820
    [No Abstract]   [Full Text] [Related]  

  • 29. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Venous thromboembolism and cancer].
    Ferrari E; Benhamou M; Berkane N; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1307-12. PubMed ID: 11794974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism and cancer: current issues and treatment updates.
    Horton J
    Cancer Control; 2005 Sep; 12 Suppl 1():3-4; quiz 38-40. PubMed ID: 16179897
    [No Abstract]   [Full Text] [Related]  

  • 32. Venous thromboembolism following total knee replacement.
    Choi BY; Huo MH
    J Surg Orthop Adv; 2007; 16(1):31-5. PubMed ID: 17371645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are patients with cancer receiving adequate treatment for thrombosis? Results from FRONTLINE.
    Wong JE
    Cancer Treat Rev; 2003 Jun; 29 Suppl 2():11-3. PubMed ID: 12887944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 38. Thromboembolism.
    Fitzmaurice D; Hobbs FR; McManus R
    Clin Evid; 2005 Dec; (14):198-215. PubMed ID: 16620405
    [No Abstract]   [Full Text] [Related]  

  • 39. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of thromboprophylaxis in malignancy.
    Kakkar AK
    Haemostasis; 2001; 31 Suppl 1():67. PubMed ID: 11990485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.